C
CDT Equity Inc. (CDT)
NCM – Real vaqt narxi. Valyuta: USD
7.85
-1.97 (-20.06%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
8.20
+0.35 (4.46%)
Bozordan keyin: Mar 27, 2026, 7:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NCM – Real vaqt narxi. Valyuta: USD
7.85
-1.97 (-20.06%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
8.20
+0.35 (4.46%)
Bozordan keyin: Mar 27, 2026, 7:59 PM EDT
CDT Equity Inc., klinik bosqichdagi ixtisoslashgan biofarmatsevtika kompaniyasi, avtoimmun kasalliklar va idiopatik erkaklar bepushtligi sohalarida qondirilmagan tibbiy ehtiyojlarni qondiradigan farmatsevtika mahsulotlarini ishlab chiqadi. Uning quvur liniyasida 2-toifali diabet, buyrak transplantatsiyasi, Xashimoto tireoiditi, uveit va erta tug'ruqni davolash uchun I bosqich sinovlarini tugatgan AZD1656; va idiopatik erkaklar bepushtligini davolash uchun I bosqich klinik sinovlarini tugatgan AZD5904 mavjud. Kompaniya yangi qattiq og'zaki dozali mahsulotlarni ishlab chiqish uchun formulani ishlab chiqish bo'yicha CDMO Agility Life Sciences bilan strategik xizmatlar shartnomasiga ega. Kompaniya ilgari Conduit Pharmaceuticals Inc. nomi bilan tanilgan va 2025-yil avgust oyida CDT Equity Inc. nomini olgan. Kompaniya 2019-yilda tashkil etilgan va Florida shtatining Neapol shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Andrew Regan | Founder, CEO & Director |
| Dr. Joanne M. Holland | Chief Scientific Officer |
| Mr. James Bligh | Co-Founder, CFO & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-18 | 8-K | form8-k.htm |
| 2026-03-09 | 8-K | form8-k.htm |
| 2026-01-30 | S-3 | forms-3.htm |
| 2026-01-22 | 8-K | form8-k.htm |
| 2026-01-02 | 8-K | form8-k.htm |
| 2025-12-12 | 8-K | form8-k.htm |
| 2025-11-13 | 10-Q | form10-q.htm |
| 2025-10-09 | 8-K | form8-k.htm |
| 2025-08-14 | 10-Q | form10-q.htm |
| 2025-08-11 | S-8 | forms-8.htm |